Annual Book Value
$2.23 B
+$2.16 B+30.69%
31 December 2023
Summary:
Neurocrine Biosciences annual book value is currently $2.23 billion, with the most recent change of +$2.16 billion (+30.69%) on 31 December 2023. During the last 3 years, it has risen by +$1.11 billion (+98.19%). NBIX annual book value is now at all-time high.NBIX Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Book Value
$2.72 B
+$209.70 M+8.36%
30 September 2024
Summary:
Neurocrine Biosciences quarterly book value is currently $2.72 billion, with the most recent change of +$209.70 million (+8.36%) on 30 September 2024. Over the past year, it has increased by +$716.80 million (+35.80%). NBIX quarterly book value is now at all-time high.NBIX Quarterly Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NBIX Book Value Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +30.7% | +35.8% |
| 3 y3 years | +98.2% | +102.0% |
| 5 y5 years | +364.3% | +373.3% |
NBIX Book Value High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +98.2% | at high | +102.0% |
| 5 y | 5 years | at high | +364.3% | at high | +373.3% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
Neurocrine Biosciences Book Value History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2.72 B(+8.4%) |
| June 2024 | - | $2.51 B(+5.2%) |
| Mar 2024 | - | $2.39 B(+6.9%) |
| Dec 2023 | $2.23 B(+30.7%) | $2.23 B(+11.5%) |
| Sept 2023 | - | $2.00 B(+8.0%) |
| June 2023 | - | $1.85 B(+10.0%) |
| Mar 2023 | - | $1.68 B(-1.4%) |
| Dec 2022 | $1.71 B(+24.3%) | $1.71 B(+10.6%) |
| Sept 2022 | - | $1.54 B(+8.5%) |
| June 2022 | - | $1.42 B(+2.3%) |
| Mar 2022 | - | $1.39 B(+1.2%) |
| Dec 2021 | $1.37 B(+22.0%) | $1.37 B(+2.1%) |
| Sept 2021 | - | $1.35 B(+5.2%) |
| June 2021 | - | $1.28 B(+6.1%) |
| Mar 2021 | - | $1.21 B(+7.1%) |
| Dec 2020 | $1.13 B(+76.8%) | $1.13 B(+40.0%) |
| Sept 2020 | - | $804.30 M(-3.2%) |
| June 2020 | - | $831.20 M(+18.7%) |
| Mar 2020 | - | $700.30 M(+10.0%) |
| Dec 2019 | $636.90 M(+32.5%) | $636.90 M(+10.9%) |
| Sept 2019 | - | $574.51 M(+18.8%) |
| June 2019 | - | $483.71 M(+18.2%) |
| Mar 2019 | - | $409.27 M(-14.9%) |
| Dec 2018 | $480.76 M(+29.2%) | $480.76 M(+7.4%) |
| Sept 2018 | - | $447.51 M(+18.6%) |
| June 2018 | - | $377.44 M(+3.6%) |
| Mar 2018 | - | $364.49 M(-2.1%) |
| Dec 2017 | $372.14 M(+18.2%) | $372.14 M(+7.1%) |
| Sept 2017 | - | $347.51 M(+0.7%) |
| June 2017 | - | $345.24 M(+39.7%) |
| Mar 2017 | - | $247.14 M(-21.5%) |
| Dec 2016 | $314.88 M(-25.8%) | $314.88 M(-10.5%) |
| Sept 2016 | - | $351.65 M(-7.7%) |
| June 2016 | - | $381.04 M(-7.7%) |
| Mar 2016 | - | $412.96 M(-2.7%) |
| Dec 2015 | $424.45 M(+103.4%) | $424.45 M(-5.0%) |
| Sept 2015 | - | $446.94 M(-4.3%) |
| June 2015 | - | $466.94 M(-3.7%) |
| Mar 2015 | - | $484.73 M(+132.3%) |
| Dec 2014 | $208.70 M(+73.3%) | $208.70 M(-6.8%) |
| Sept 2014 | - | $224.04 M(-5.4%) |
| June 2014 | - | $236.84 M(-4.1%) |
| Mar 2014 | - | $247.06 M(+105.2%) |
| Dec 2013 | $120.41 M(-22.0%) | $120.41 M(-6.9%) |
| Sept 2013 | - | $129.29 M(-4.9%) |
| June 2013 | - | $136.02 M(-6.2%) |
| Mar 2013 | - | $144.95 M(-6.1%) |
| Dec 2012 | $154.37 M(+156.9%) | $154.37 M(+7.7%) |
| Sept 2012 | - | $143.31 M(-1.0%) |
| June 2012 | - | $144.73 M(+0.6%) |
| Mar 2012 | - | $143.83 M(+139.4%) |
| Dec 2011 | $60.08 M(+210.6%) | $60.08 M(+4.0%) |
| Sept 2011 | - | $57.75 M(+126.0%) |
| June 2011 | - | $25.56 M(+11.2%) |
| Mar 2011 | - | $22.99 M(+18.9%) |
| Dec 2010 | $19.34 M | $19.34 M(+16.2%) |
| Sept 2010 | - | $16.65 M(+34.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2010 | - | $12.41 M(-25.8%) |
| Mar 2010 | - | $16.72 M(+322.9%) |
| Dec 2009 | $3.95 M(-89.2%) | $3.95 M(+267.8%) |
| Sept 2009 | - | $1.07 M(-85.4%) |
| June 2009 | - | $7.35 M(-61.6%) |
| Mar 2009 | - | $19.11 M(-48.0%) |
| Dec 2008 | $36.77 M(-69.0%) | $36.77 M(-42.2%) |
| Sept 2008 | - | $63.65 M(-20.3%) |
| June 2008 | - | $79.84 M(-19.1%) |
| Mar 2008 | - | $98.67 M(-16.9%) |
| Dec 2007 | $118.70 M(-62.3%) | $118.70 M(-51.5%) |
| Sept 2007 | - | $244.95 M(-9.0%) |
| June 2007 | - | $269.05 M(-7.8%) |
| Mar 2007 | - | $291.70 M(-7.3%) |
| Dec 2006 | $314.72 M(-19.3%) | $314.72 M(-3.6%) |
| Sept 2006 | - | $326.48 M(-9.8%) |
| June 2006 | - | $361.77 M(-5.7%) |
| Mar 2006 | - | $383.83 M(-1.6%) |
| Dec 2005 | $390.10 M(-0.9%) | $390.10 M(-3.4%) |
| Sept 2005 | - | $403.74 M(+8.5%) |
| June 2005 | - | $372.02 M(-0.7%) |
| Mar 2005 | - | $374.72 M(-4.9%) |
| Dec 2004 | $393.83 M(+0.7%) | $393.83 M(-4.5%) |
| Sept 2004 | - | $412.56 M(+0.2%) |
| June 2004 | - | $411.54 M(-3.3%) |
| Mar 2004 | - | $425.40 M(+8.8%) |
| Dec 2003 | $391.12 M(+74.4%) | $391.12 M(+1.1%) |
| Sept 2003 | - | $386.83 M(+84.2%) |
| June 2003 | - | $209.97 M(-2.4%) |
| Mar 2003 | - | $215.21 M(-4.0%) |
| Dec 2002 | $224.25 M(-27.8%) | $224.25 M(-13.7%) |
| Sept 2002 | - | $259.83 M(-6.3%) |
| June 2002 | - | $277.23 M(-5.7%) |
| Mar 2002 | - | $293.93 M(-5.3%) |
| Dec 2001 | $310.39 M(+90.2%) | $310.39 M(+113.3%) |
| Sept 2001 | - | $145.53 M(+1.9%) |
| June 2001 | - | $142.87 M(-6.8%) |
| Mar 2001 | - | $153.29 M(-6.1%) |
| Dec 2000 | $163.21 M(+69.3%) | $163.21 M(+100.4%) |
| Sept 2000 | - | $81.44 M(-6.2%) |
| June 2000 | - | $86.85 M(-5.6%) |
| Mar 2000 | - | $92.04 M(-4.5%) |
| Dec 1999 | $96.40 M(+33.9%) | $96.40 M(+62.6%) |
| Sept 1999 | - | $59.30 M(-6.3%) |
| June 1999 | - | $63.30 M(-6.9%) |
| Mar 1999 | - | $68.00 M(-5.6%) |
| Dec 1998 | $72.00 M(-13.5%) | $72.00 M(-8.5%) |
| Sept 1998 | - | $78.70 M(+0.4%) |
| June 1998 | - | $78.40 M(-4.6%) |
| Mar 1998 | - | $82.20 M(-1.2%) |
| Dec 1997 | $83.20 M(+14.3%) | $83.20 M(+6.0%) |
| Sept 1997 | - | $78.50 M(+1.4%) |
| June 1997 | - | $77.40 M(+0.3%) |
| Mar 1997 | - | $77.20 M(+6.0%) |
| Dec 1996 | $72.80 M | $72.80 M(+6.7%) |
| Sept 1996 | - | $68.20 M(-0.4%) |
| June 1996 | - | $68.50 M(+183.1%) |
| Mar 1996 | - | $24.20 M |
FAQ
- What is Neurocrine Biosciences annual book value?
- What is the all time high annual book value for Neurocrine Biosciences?
- What is Neurocrine Biosciences annual book value year-on-year change?
- What is Neurocrine Biosciences quarterly book value?
- What is the all time high quarterly book value for Neurocrine Biosciences?
- What is Neurocrine Biosciences quarterly book value year-on-year change?
What is Neurocrine Biosciences annual book value?
The current annual book value of NBIX is $2.23 B
What is the all time high annual book value for Neurocrine Biosciences?
Neurocrine Biosciences all-time high annual book value is $2.23 B
What is Neurocrine Biosciences annual book value year-on-year change?
Over the past year, NBIX annual book value has changed by +$524.20 M (+30.69%)
What is Neurocrine Biosciences quarterly book value?
The current quarterly book value of NBIX is $2.72 B
What is the all time high quarterly book value for Neurocrine Biosciences?
Neurocrine Biosciences all-time high quarterly book value is $2.72 B
What is Neurocrine Biosciences quarterly book value year-on-year change?
Over the past year, NBIX quarterly book value has changed by +$716.80 M (+35.80%)